What the evidence says about AI companion apps and loneliness
Companion chatbots eased loneliness as much as talking to a person in one set of studies — and the same research documents emotional dependence and users who are lonelier to begin with.
For how we live.
Companion chatbots eased loneliness as much as talking to a person in one set of studies — and the same research documents emotional dependence and users who are lonelier to begin with.
Restrictive English schools cut phone use during the school day but not overall — and teenagers' wellbeing was no better than at schools that allow phones. What tracks with worse mental health is heavy, problematic use.
A smartphone app delivering CBT cut tinnitus-related distress about 20 points more than a sham app in 60 adults, and the effect held for two months. The trial was small and industry-funded.
A 2025 rule created billing codes for FDA-cleared mental-health software. The 2026 rule adds short-episode remote-monitoring codes but declines to widen the digital-therapy benefit.
A survey of seven countries found the youth mental health app market dominated by paid journaling and meditation apps. The AI-powered ones show early promise on symptoms — and none had checked for harm.
Across 34 trials, mindfulness apps produced small effects on stress, anxiety and depression, and none on general distress. A 2026 review confirms they can help without a facilitator — at low certainty.
Most wellness apps make no disease claim and face no federal review. Into that gap, US states are writing their own AI-in-mental-health laws — four already diverge, leaving users unevenly protected.
A review of 110 studies found that 52% of trialled self-guided apps were publicly available — and that evidence quality had no bearing on which ones made it to an app store.
Pooled across 48 trials, chatbots cut depression, anxiety and stress by small amounts. But a review of purpose-built mental health chatbots found crisis-referral protocols underdeveloped and missed suicidal ideation.
The largest syntheses find apps beat doing nothing on depression and anxiety by about a third of a standard deviation — but the edge shrinks against real treatment, and one umbrella review found no convincing proof.
A meta-regression of 169 trials coded 34 therapeutic ingredients. The most common — psychoeducation, relaxation, mindfulness — were not the ones that best predicted getting better.